`
`RFB002A - Lucentis pre-filled syringes
`
`IPT meeting, March 19th 2007
`
`1 RFB002A - IPT meeting / March 19th 2007
`
`(_!) NOVART I S
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION , SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH}01863737
`
`Novartis Exhibit 2145.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development
`Executive summary
`
`2 RFB002A- IPT meeting I March 19th 2007
`
`NOVARTIS
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863737
`
`Novartis Exhibit 2145.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development
`Lucentis PFS options comparison
`
`Options
`
`Approval Approval Pros
`previous new
`budget
`budget
`
`Cons
`
`3 RFB002A - IPT meeting/ March 19th 2007
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH}01863737
`
`Novartis Exhibit 2145.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development - - - - - - - - - - - - - - -
`Next steps
`
`4 RFB002A- IPT meeting I March 19th 2007
`
`lf NOVARTIS
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863737
`
`Novartis Exhibit 2145.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development - - - - - - - - - - - - - - - -
`Back up slides
`
`5 RFB002A- IPT meeting I March 19th 2007
`
`lf NOVARTIS
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863737
`
`Novartis Exhibit 2145.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development - - - - - - - - - - - - - - - -
`Lucentis pre-filled - Revised development strategy
`
`6 RFB002A - IPT meeting/ March 19th 2007
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION , SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH}01863737
`
`Novartis Exhibit 2145.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development
`Lucentis PFS - Timelines comparison (previous budget)
`
`7 RFB002A - IPT meeting/ March 19th 2007
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH}01863737
`
`Novartis Exhibit 2145.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development
`Lucentis PFS -Timelines comparison (new budget)
`
`8 RFB002A - IPT meeting/ March 19th 2007
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION , SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH}01863737
`
`Novartis Exhibit 2145.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Global Technical Research & Development
`Lucentis PFS-2007 budget reduction
`
`9 RFB002A- IPT meeting I March 19th 2007
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863737
`
`Novartis Exhibit 2145.009
`Regeneron v. Novartis, IPR2021-00816
`
`